Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form 1052303004
SNOMED CT code
| SNOMED code | 1052303004 |
|---|---|
| name | Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form |
| status | active |
| date introduced | 2021-01-31 |
| fully specified name(s) | Product containing atoltivimab and maftivimab and odesivimab in parenteral dose form (medicinal product form) |
| synonyms | Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form |
| attributes - group0 | |
| Has manufactured dose form | Parenteral dose form 385287007 |
| Plays role | Antiviral therapeutic role 788077006 |
| attributes - group1 | |
| Has active ingredient | Atoltivimab 1052216001 |
| attributes - group2 | |
| Has active ingredient | Maftivimab 1052217005 |
| attributes - group3 | |
| Has active ingredient | Odesivimab 1052218000 |
| parents |
|
| children | Atoltivimab and maftivimab and odesivimab only product in parenteral dose form 1052304005 |
| hierarchies | a selection of possible paths SNOMED CT Concept 138875005Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Medicinal product categorized by disposition 766779001 Atoltivimab- and maftivimab- and odesivimab-containing product 1052301002 Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form 1052303004 SNOMED CT Concept 138875005 Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as parenteral dose form 440132002 Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form 1052303004 |
| ancestors | sorted most to least specific
|
| cpt crosswalks | |
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com